6YVR

Crystal structure of the neurotensin receptor 1 in complex with the peptide full agonist NTS8-13

これはPDB形式変換不可エントリーです。

6YVR の概要

• エントリーDOI: 10.2210/pdb6yvr/pdb
• 分子名称: Neurotensin receptor type 1,Neurotensin receptor type 1,DARPin crystallisation chaperone, neurotensin NTS8-13 (full agonist), nonyl beta-D-glucopyranoside, ... (4 entities in total)
• 機能のキーワード: gpcr-ligand complex, ntsr1, nts8-13, full agonist, membrane protein
• 由来する生物種: Rattus norvegicus (Rat); 詳細
• タンパク質・核酸の鎖数: 4
• 化学式量合計: 110495.83

構造登録者

Deluigi, M.,Merklinger, L.,Hilge, M.,Ernst, P.,Klipp, A.,Klenk, C.,Plueckthun, A. (登録日: 2020-04-28, 公開日: 2021-02-10, 最終更新日: 2024-11-13)

主引用文献

Deluigi, M.,Klipp, A.,Klenk, C.,Merklinger, L.,Eberle, S.A.,Morstein, L.,Heine, P.,Mittl, P.R.E.,Ernst, P.,Kamenecka, T.M.,He, Y.,Vacca, S.,Egloff, P.,Honegger, A.,Pluckthun, A.
Complexes of the neurotensin receptor 1 with small-molecule ligands reveal structural determinants of full, partial, and inverse agonism.
Sci Adv, 7:-, 2021

PubMed Abstract: Neurotensin receptor 1 (NTSR1) and related G protein-coupled receptors of the ghrelin family are clinically unexploited, and several mechanistic aspects of their activation and inactivation have remained unclear. Enabled by a new crystallization design, we present five new structures: apo-state NTSR1 as well as complexes with nonpeptide inverse agonists SR48692 and SR142948A, partial agonist RTI-3a, and the novel full agonist SRI-9829, providing structural rationales on how ligands modulate NTSR1. The inverse agonists favor a large extracellular opening of helices VI and VII, undescribed so far for NTSR1, causing a constriction of the intracellular portion. In contrast, the full and partial agonists induce a binding site contraction, and their efficacy correlates with the ability to mimic the binding mode of the endogenous agonist neurotensin. Providing evidence of helical and side-chain rearrangements modulating receptor activation, our structural and functional data expand the mechanistic understanding of NTSR1 and potentially other peptidergic receptors.

PubMed: 33571132
DOI: 10.1126/sciadv.abe5504

実験手法

X-RAY DIFFRACTION (2.458 Å)